Member Info for PhatStyle4321

Each and every investor have their own strategy, whether it is short/long term.

The facts are that management have delivered on everything they have said so far. The market has full trust that everything that has been said will be delivered upon.

AxisBiotix delivered above and beyond news and it is now a transition from results to commercialisation.

Croda update suggests that everything is running as expected and we will should be due one anytime.

Also as Elric explains Skinbio doesn’t only have these pillars, another agreement could land at anytime.

I personally have been buying more shares here, this price offers great value even up to £1. Every week past is one week closer to Q4.

Suggest people subsribe and read the article on ************* - TW explains the shares could 6 bag from here wow

I agree to Belgrano, big background buys show more confidence that our technology is the future.

So glad that our results are getting positive press

Destiny just released a RNS on the microbiome further supporting that this new part of research is an important factor for our overall health.

https://www.dermatologytimes.com/view/food-supplement-demonstrates-positive-results-in-psoriasis-therapy

Wow great article, emphasizing AxisBiotix as a therapy for Psoriasis. Absolutely wonderful, once again so happy to be invested in a company that helps people

Knew we would be back over 70p in no time, sellers that top sliced are going to be very disappointed, £1 incoming

I fear that these sellers will be regretting their decision as we approach Q3. Tyndall have a brilliant reputation and had added 1% when we were mid 70’s. This shows huge confidence in the company and the results. Onwards and upwards

@Ted, not my calculations but Elricos, he was mid way doing them in his post, but stopped??? Maybe an email to subscribers on his thoughts ?

With all the opportunities and positivity over the weekend, especially from Elrics interview we should see a big surge over 70p and getting back to recent ATH’s, traders have excited and now long termers will be entering or topping up. Good day all

Surely you can’t stop there, could you finish your equation hypothetically speaking ? It would be interesting to see your calculations

Well said, Belgrano, one thing to note is that Stuart has never let the market down, not once, therefore if this product is going to be soft launched in Q4, then we really only have 3-6months for this to occur. In addition, we have pricing and the opening subscription numbers. However the Croda beauty parade also ties within Q4 also, not to mention any updates on any of the new pillars which were all in discussions per covid. I am beginning to think the next few months are going to be huge for the company.

When an investors research is done solely by google search and hasn’t even taken the time to look at the companies website or even email the company with the specific questions then to me, that only look likes cheap ways to sos credit the company.

He has now then received adequate answers to those questions and then decides they aren’t good enough. However like Elrico has said this investment isn’t for him and as Ted said we won’t be missing his £5.

I am also with Belgrano on commending Elrico for a great, informative interview with Stuart Ashman. The £35 subscription is well worth it and gives a lot of insight. I think a lot of those answers will clear up a lot of doubt and the potential will be pondering in investors minds over the bank holiday weekend

Wow, this is just laughable.

Each to their own I guess, you sound like a very successful investor indeed.

Do you really think companies would like to replicate this product? To then test it out and conduct a trial?

Let’s take Croda for example, they are worth north of £6billion, they know it would take them a lot more time and resources to replicate the ingredient that Skinbio have developed, it has taken years, years of knowledge and research.

They know the product works and therefore have partnered with Skinbio, not merely to try and replicate their product. I guess amateurs will try to act professional.

To another point, you were trying to find your answers on Google, but didn’t care to even research on the companies website beforehand. These amateur tactics to try and derail the company are pathetic and won’t work.

Is this all you have to try and pointlessly deramp. You are not a scientist and probably don’t have a specialist in any skill going. Cath O’Neil and the team leading Skinbio are scientists and very established in there field. You, my friend have only used google to find answers that are way beyond you. So please if you are trying deramp in order to get in at a better price then try harder.

Interview may reveal some hidden nuggets and clarify some of the points on the RNS. If anyone can do it, Elric can. The share price is just extremely cheap for what we have coming and the potential. If the efficacy for the probiotic was 50% I could understand why we would drop this much but 72% is extremely high and especially with zero side effects.

I believe the interview with Elrico will answer a lot of questions but more importantly highlight the opportunity and potential for Skinbio, I really just don’t think people realise that this could a billion dollar company.

Good choice, if we take a step back and remember after the results RNS we hit 88p. This is massive. We have only gone down due to sellers taking profit. It won’t be long before we are back there, especially as it’s pay day weekend. I bet Elricos interview will really clear things up.

Personally I just see so much of Opti value targeted to Skinbio, we all know that Skins is the golden nugget, Opti to me is just stale, I had a few shares thinking this would eventually increase but sold them within a month. Skinbio is really good value IMO, especially after ground breaking news

Don’t forget we have the Elrico interview tonight with Stuart Ashman. I believe Elric will unveil a lot more than others and will do us justice. This will be after hours and so any little nuggets he can get will surely give us a nice boost Tuesday.

I believe after the interview with Elric, next week will bring a lot more buying. Institution will have completed meetings on the company and realise how much the company has de risked. The prospects are huge and will all depend on the numbers of subscribers, but after looking at the pictures and the testimonials, psoriasis suffers will jump on this all day long. Key thing here is that there are no side effects what so ever. Absolutely game changing

Looks like bottom found, a lot lower than I thought but I guess investors have made substantial profits and want to realise theses. Personally I think they will regret selling at these stupidly low prices. A company like this are 1 in a billion, and will be the reason you are up all night wishing you had more.

Croda deal and a product launch all happening very soon. Croda update could hit anytime also. All exciting here and company hugely derisked.